Nav: Home

Single gene mutation muddying Parkinson's risk forecasts

June 03, 2004

PORTLAND, Ore. - A peculiar form of a gene mutation known to increase a person's risk for Parkinson's disease is puzzling doctors about how to counsel patients who have the anomaly.

A study by researchers at the Oregon Health & Science University School of Medicine's Parkinson Center of Oregon, the University of Washington School of Medicine and the New York State Department of Health, Wadsworth Center, raises concerns about whether patients testing positive for a single mutation of the parkin gene, rather than the two mutations typically required for developing Parkinson's, can be accurately informed about their risks of developing the disease or passing it on to their children.

The study represents "a call for getting more information about the gene," said John "Jay" G. Nutt, M.D., OHSU professor of neurology, and physiology and pharmacology, and Parkinson center director. "What are the clinical implications of finding this gene?"

What's alarmed doctors is that in the clinical setting, the single mutation appears to be common: 18 percent of patients with early-onset Parkinson's disease - those diagnosed before age 40 - tested positive for parkin gene mutations, and of that group, 70 percent had only one mutation.

"It was formerly thought that two mutations caused the disease, that it was recessive, that you had to get one copy of the gene from each parent" to develop the disease, said Nutt, also director of the Parkinson's Disease Research, Education, and Clinical Center (PADRECC) at the Portland Veterans Affairs Medical Center.

These latest findings, however, have baffled Parkinson's disease scientists.

"This raises all sorts of red flags for testing for parkin. How are you going to use this information? How are you going to counsel patients? What does this really mean?" Nutt said.

Whatever the cause, Nutt believes counseling single-mutation patients about their risks of developing Parkinson's disease will be difficult at best.

"You just don't know," Nutt said. "Clearly, if you have two copies, then we think you're at high risk for developing Parkinson's disease. What would be the risk for your child? If your mate doesn't have abnormal genes, you would say your risk is very low." But the study "raises questions about how you would interpret any gene testing," he added. "It makes counseling basically impossible."

Although parkin mutations are the most commonly identified cause of Parkinson's disease, the number of Americans with early-onset Parkinson's disease that has the parkin mutation is unknown. Previous reports established a range of between 16 percent and 49 percent, but the estimates were based on special populations selected for genetic studies, so the rates may have been inflated.

In addition, despite the large percentage of individuals with early-onset Parkinson's who were parkin-positive, none of 96 controls had any mutation. "So exactly how common it is, I think, is still not known," Nutt said.

So far, symptoms of early-onset Parkinson's disease are the same for individuals with or without the parkin mutation. In fact, parkin cases are distinguishable only by molecular testing.

"At this point, there are no clinical implications as far as treatment of the patient," Nutt said.

In the meantime, researchers will continue to seek a better understanding of how the single mutation is inherited and the frequency with which it occurs among carriers. They are working closely with Haydeh Payami, Ph.D., former OHSU professor of genetics and neurology who is helping Nutt track some 700 Parkinson's patients as head of the NeuroGenetics Research Program at the New York State Department of Health's Wadsworth Center.

Nutt's collaborators included: Payami, research scientist, Wadsworth Center, and adjunct professor of neurology, Albany Medical College; Stephen T. Gancher, M.D., adjunct associate professor of neurology, OHSU School of Medicine; Parvoneh Poorkaj Navas, Ph.D., research assistant professor of psychiatry and behavioral sciences, UW; Thomas D. Bird, M.D., professor of neurology, UW; Ellen J. Steinbart, research nurse, Alzheimers Disease Research Center, UW; and Gerard D. Schellenberg, Ph.D., research professor of medicine in the Division of Gerontology and Geriatric Medicine, and adjunct research professor of neurology, UW.
-end-
The study was supported by the National Institutes of Health and PADRECC.

To access all OHSU news releases, visit www.ohsu.edu/news/

Oregon Health & Science University

Related Gene Mutation Articles:

Gene mutation linked to retinitis pigmentosa in Southwestern US Hispanic families
Thirty-six percent of Hispanic families in the U.S. with a common form of retinitis pigmentosa got the disease because they carry a mutation of the arrestin-1 gene, according to a new study from researchers at The University of Texas Health Science Center at Houston (UTHealth) School of Public Health.
Gene mutation may speed up memory loss in Alzheimer's disease
A gene mutation may accelerate the loss of memory and thinking skills in people who are at risk for Alzheimer's disease, according to a study published in the May 3, 2017, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Gene mutation helps explain night owl behavior
Some people stay up late and have trouble getting up in the morning because their internal clock is genetically programmed to run slowly, according to a study published April 6 in Cell.
Gene mutation may be linked to unexplained female infertility
Researchers at Baylor College of Medicine, Texas Children's Hospital and Rice University have uncovered a gene mutation that may provide answers to unexplained female infertility.
One gene mutation, two diseases, many insights into human heart function
Scientists at the Gladstone Institutes linked a single gene mutation to two types of heart disease: one causes a hole in the heart of infants, and the other causes heart failure.
Brain study confirms gene mutation link to psychiatric disorders
Brain scans have revealed how a genetic mutation linked to major psychiatric disorders affects the structure, function and chemistry of the brain.
Gene mutation 'hotspots' linked to better breast cancer outcomes
Using a database of human tumor genomic data, researchers at the University of California San Diego, School of Medicine and Moores Cancer Center discovered that mutation hotspots known as kataegis are a positive marker in breast cancer -- patients with kataegis have less invasive tumors and better prognoses.
Gene mutation causes juvenile mortality in calves
Based on genome data, breeders and scientists are able to determine which hereditary factors and which genetic diseases cattle pass on to their offspring.
First gene mutation explaining development of multiple sclerosis found
Although multiple sclerosis is known to run in certain families, attempts to find genes linked to the disease have been elusive.
Second gene modifies effect of mutation in a dog model of ALS
Canine Degenerative Myelopathy (DM) is a neurodegenerative disease in dogs with similarities to ALS in humans.

Related Gene Mutation Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Digital Manipulation
Technology has reshaped our lives in amazing ways. But at what cost? This hour, TED speakers reveal how what we see, read, believe — even how we vote — can be manipulated by the technology we use. Guests include journalist Carole Cadwalladr, consumer advocate Finn Myrstad, writer and marketing professor Scott Galloway, behavioral designer Nir Eyal, and computer graphics researcher Doug Roble.
Now Playing: Science for the People

#529 Do You Really Want to Find Out Who's Your Daddy?
At least some of you by now have probably spit into a tube and mailed it off to find out who your closest relatives are, where you might be from, and what terrible diseases might await you. But what exactly did you find out? And what did you give away? In this live panel at Awesome Con we bring in science writer Tina Saey to talk about all her DNA testing, and bioethicist Debra Mathews, to determine whether Tina should have done it at all. Related links: What FamilyTreeDNA sharing genetic data with police means for you Crime solvers embraced...